Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Novartis”
- Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus NephritisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Lupus Nephritis
United States, Argentina, Brazil, Canada, Chile +22 more
- A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed SteroidsActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Primary Immune Thrombocytopenia
United States, Argentina, Austria, Belgium, China +19 more
- Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Polymyalgia Rheumatica
United States, Argentina, Australia, Belgium, Brazil +17 more
- A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis SuppurativaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
United States, Argentina, Austria, Belgium, Canada +14 more
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
United States, Argentina, Australia, Austria, Belgium +33 more
- Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Systemic Lupus Erythematosus
United States, Argentina, Brazil, Bulgaria, Canada +14 more
- Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALLActive Not Recruiting
Sponsor: Dana-Farber Cancer Institute
Acute Lymphoblastic Leukemia ALL
United States
Sponsor: Novartis Pharmaceuticals
Tuberous Sclerosis Complex
United States, Australia, Belgium, Canada, Colombia +13 more
Sponsor: Novartis Pharmaceuticals
Multiple Sclerosis
United States
- A Study of Secukinumab to Evaluate Maintenance of Response in Participants With Non-radiographic Axial Spondyloarthritis Who Achieved RemissionActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Non-radiographic Axial Spondyloarthritis
Belgium, Brazil, Colombia, Czechia, France +13 more
Sponsor: Novartis Pharmaceuticals
Breast Cancer
Belgium, Bulgaria, Canada, Czechia, Denmark +12 more
- A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)Active Not Recruiting
Sponsor: Novartis Pharmaceuticals
Hidradenitis Suppurativa
United States, Argentina, Australia, Bulgaria, Canada +15 more
- A Study of Patient Characteristics, Co-Morbidities, and Treatment Patterns in Chronic Myeloid Leukemia Patients in KuwaitNot Yet Recruiting
Sponsor: Novartis Pharmaceuticals
Leukemia, Myeloid, Chronic-Phase
- CINC424A2X01B Rollover ProtocolActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Primary Myelofibrosis · Polycythemia Vera · Graft Versus Host Disease · Acute Myeloid Leukemia
Australia, Belgium, Bulgaria, Canada, Chile +20 more
- Iptacopan in Patients With ANCA Associated VasculitisActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
United States, Argentina, Australia, Austria, Belgium +10 more
- A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistaminesActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Chronic Inducible Urticaria
United States, Argentina, Australia, Brazil, Canada +23 more
Sponsor: Brown University
Sickle Cell Anemia in Children · Sickle Cell Disease
Angola
- [177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast CancerActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Breast Cancer
United States, China, France, Germany, Poland +2 more
Sponsor: Novartis Pharmaceuticals
Atopic Dermatitis
United States, Argentina, Canada, China, Czechia +12 more
Sponsor: Novartis Pharmaceuticals
Asthma
Argentina, Austria, Brazil, Bulgaria, Colombia +12 more
- A Study of Efficacy and Safety of Ianalumab in Previously Treated Patients With Warm Autoimmune Hemolytic AnemiaActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Warm Autoimmune Hemolytic Anemia (wAIHA)
United States, Argentina, Australia, China, France +11 more
- A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MSNot Yet Recruiting
Sponsor: Moein Amin
Multiple Sclerosis (MS) - Relapsing-remitting · Multiple Sclerosis (MS) Secondary Progressive · Multiple Sclerosis (MS) Primary Progressive
United States
- A Study to Assess the Efficacy, Safety and Pharmacokinetics of EYU688 in Patients With Dengue FeverRecruiting
Sponsor: Novartis Pharmaceuticals
Dengue
Brazil, Colombia, India, Malaysia, Mexico +2 more
- A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and AtezolizumabActive Not Recruiting
Sponsor: Novartis Pharmaceuticals
Extensive Stage Small Cell Lung Cancer
United States, Austria, Canada, China, Czechia +7 more
Sponsor: Novartis Pharmaceuticals
Chronic Kidney Disease
United States, Germany